A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Adding a little Percocet to the portfolio. Pharma dealing with various pain control products offers strong balance sheet with high ROE; likely to show relative strength later in the summer in advance of FDA decision on marketing application for NEBIDO - buyer around $18
I'm hoping to pick this up around $15 for my real portfolio, but $16 isn't too bad for my CAPS entry. :) Carries quite a bit of debt, but cash flow looks good.